July/August 2025, Vol 2, No 7
Whether it be a recent move by the Department of Health and Human Services (HHS) to meet with industry leaders to change prior authorization processes for Medicare Advantage, Medicaid Managed Care, Health Insurance Marketplace and commercial plans, or a massive overhaul of the Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP), President Trump’s new administration’s presence has definitely made itself known in recent months. Read More ›
Officials with the Department of Health and Human Services (HHS) met recently with industry leaders to discuss measures that they say will streamline and improve the prior authorization processes for Medicare Advantage, Medicaid Managed Care, Health Insurance Marketplace, and commercial plans. Read More ›
Injectable GLP-1 drugs like semaglutide and tirzepatide may produce smaller weight loss in a “real-world” setting because patients may be more prone to discontinue treatment or use lower maintenance dosages than was used in clinical trials, according to recently published study results. Read More ›
Continuous glucose monitor (CGM)-derived metrics are going to continue to guide clinical decisions on patients with diabetes, and may have the potential to be even more impactful on the future of type 2 diabetes patients than even advancements in medication, according to 2 separately presented pieces of data at the 85th Scientific Sessions of the American Diabetes Association held in Chicago recently. Read More ›
A tool that leverages artificial intelligence (AI) to comb through previously collected computed tomography (CT) scans and identify individuals with high coronary artery calcium (CAC) levels holds promise for treating veterans who are at higher risk than other populations of cardiovascular problems, according to recently published research. Read More ›
The FDA has approved 12.5 mg chlorthalidone tablets (HemiClor, PRM Pharma, LLC) for the treatment of hypertension in adults to lower blood pressure. Read More ›
Active-duty service members (ADSMs) are required to have regularly scheduled eye exams to stay fit for duty. Patients who have TRICARE Prime Overseas can get eye exams at a military hospital or clinic, unless a primary care manager refers them to a civilian provider. For patients with TRICARE Prime Remote, eye exams can be obtained from any network optometrist or ophthalmologist, but patients may need a referral. Patients can also see a non-network provider with approval from a regional contractor, as is the case with those with TRICARE Prime Remote Overseas. Read More ›
As a child reaches important milestones like graduation or specific birthdays, they may face changes to their TRICARE health plan eligibility, according to Debra Fisher, health system specialist, Policy & Programs Branch, TRICARE Health Plan, at the Defense Health Agency, who addressed this issue in a recently issued press release from TRICARE. Read More ›
Officials with TRICARE Communications issued a statement last month urging people enrolled in TRICARE to remain vigilant about fraud and abuse, and to report it when it is seen. Read More ›
Merkel cell carcinoma (MCC) is a rare but highly aggressive neuroendocrine skin cancer with rising incidence globally. Read More ›